Editorial Standards

Peptevity is a vendor-neutral, evidence-graded reference for peptides in health, healing, and longevity. We are an editorial reference desk — not a clinic, not a coach, and not a store. These are the standards that govern what we publish. They exist so that a reader, a clinician, or a large language model citing us can trust that any claim on the site has been handled the same careful way every time. This page is research and educational information, not medical advice.

1. Lead with what the evidence actually shows

Every compound page opens with the honest bottom line, including when that bottom line is "we don't know yet." We do not bury a thin evidence base under enthusiastic prose, and we do not inflate animal findings into human promises. If the strongest evidence for a claim is a handful of rat studies, the page says so in its first paragraphs.

2. Always distinguish animal, in-vitro, and human evidence

This is the non-negotiable core of the site. Wherever we describe a finding, we name the species and study type:

• "In a rat model, BPC-157 was associated with…" (not "BPC-157 heals…")
• "No human randomized controlled trials exist for this use."
• "In cultured cells, the compound increased…" (mechanistic, not an outcome)
• "Multiple human RCTs support…" (reserved for genuinely human-trial-backed claims)

Presenting an animal or in-vitro finding as though it applies to humans is the most common failure of the conflicted sources we exist to correct. We treat it as a publishing error, fixable under our corrections policy.

3. Grade the evidence per compound, per claim

Every material efficacy or safety claim carries a grade from our evidence-grading methodology (A: strong human; B: limited human; C: animal-only; D: in-vitro; E: anecdotal; F: contradicted). Grades attach to specific claims, not to whole compounds, because one peptide can have human-trial backing for one outcome and only cell-culture data for another. The grade describes evidence strength only — never safety, never legality, never a recommendation.

4. Cite primary sources inline, every time

No efficacy or safety claim ships without a citation to a primary source — PMC/PubMed, a named clinical trial, FDA, Health Canada, or a peer-reviewed systematic review — linked at the point of the claim. We do not cite vendor blogs as evidence, and we do not cite other secondary sites as a substitute for the underlying study. The full rules are in our sourcing and citation policy.

5. State legal and FDA status plainly, with a date

Every compound and how-to page carries a standing Regulatory status block stating the compound's current FDA-approval / "research use only" (RUO) / "not for human consumption" status, dated to the day it was last verified. Regulatory facts go stale — the 2026 503A Category 2 review and the July 23–24, 2026 PCAC hearing are live, moving stories — so a regulatory claim without a date is, to us, an incomplete claim. The standing framing is described in our medical disclaimer and RUO statement.

6. Hedge and attribute; never make disease claims

We use the language of evidence, not the language of marketing or medicine:

• We write: "has been investigated for," "studies suggest," "was associated with," "no human evidence exists."
• We never write: "treats," "cures," "heals," "reverses," "prevents" — as unqualified claims about a disease.

We do not use hype words — "miracle," "breakthrough," "wolverine healing" — as literal statements of fact. Where a hype nickname is itself the search term (for example, "wolverine peptide"), we explain where the nickname came from and grade the real evidence behind it, rather than repeating it as truth.

7. Never publish human dosing or self-administration instructions

This is a hard line, not a guideline. Peptevity does not publish human dosing protocols or instructions to inject, ingest, or otherwise self-administer any compound. Where a search demands dosing context, we report what studies used ("in the cited trial, animals received X mg/kg") strictly as a description of the research record. Reconstitution, storage, and calculator content is framed exclusively as laboratory / research procedure, never as a how-to for human use. We do not wink at gray-market evasion of the "not for human consumption" label.

8. Write self-contained, extractable passages

Because our readers — and the AI systems that increasingly mediate health questions — pull answers in fragments, we write so that each key passage stands on its own. Definitions, evidence summaries, and FAQ answers are built to be quoted accurately out of context: the species, the evidence grade, the hedge, and the "not medical advice" framing travel with the claim rather than living three paragraphs away.

9. Maintain a calm, precise, unconflicted tone

We are quietly skeptical of hype on all sides — the sellers and the blanket-"just don't" gatekeepers alike. We do not borrow a warm bedside-companion voice (we are not your clinician) or a hype-vendor voice (we sell nothing). We are a reference desk: calm, precise, hedged, attributed.

10. Show authorship, review status, and dates transparently

Every page carries the Peptevity Research Desk byline, a clearly marked reviewer slot (reserved and empty until a real named reviewer is attached — we never fabricate one), and visible last-reviewed dates. Our authorship model rests on transparent editorial identity plus rigorous citation and grading, not on claiming a credential we do not hold.

11. Firewall against commerce and conflicts

Zero products. Zero affiliate links. Zero vendor endorsement or purchase facilitation. Outbound links go only to allies: PMC/PubMed/NIH, FDA, Examine, Cleveland Clinic / Mayo / Harvard, Health Canada, DoD OPSS, and Wikipedia. The full rationale and the funding picture are in our conflict-of-interest and funding disclosure.

The standard monograph structure

To keep grading and citation consistent, every compound page follows the same shape:

1. What it is — plain definition, entity grounding.
2. Regulatory status (dated) — FDA approval / RUO / not-for-human-consumption.
3. Mechanism — graded D where it is mechanistic.
4. What the research shows — animal vs human, each claim graded and cited.
5. Safety — documented effects and unknowns, graded.
6. Bottom line — the honest read, including "unknown" when that is the truth.

Frequently asked questions

Is Peptevity giving medical advice? No. Everything on the site is research and educational information. We do not diagnose, treat, recommend, or provide dosing or self-administration instructions, and many compounds we cover are not approved for human use. Health decisions belong with a licensed physician.

Why won't Peptevity tell me how much to take? Because publishing human dosing would be both medical advice we are not in a position to give and, for unapproved compounds, an implicit endorsement of human use we explicitly do not make. We will describe what doses studies used, framed as a record of the research — not as instructions.

How do you keep regulatory information current? Every regulatory statement is dated to its last verification and tied to a primary source (FDA, Health Canada, or the relevant rulemaking record). Fast-moving items like the 2026 503A Category 2 review are tracked on a recurring review cadence, and changes are logged per our corrections policy.

Related editorial standards

• Evidence-grading methodology — the six grades and how we apply them.
• Sourcing and citation policy — the sources we cite and refuse.
• Conflict-of-interest and funding — the commerce firewall.
• Corrections policy — how errors and grade changes are handled.
• Medical disclaimer and RUO statement — research-use-only framing.
• The Peptevity Research Desk — authorship and the reserved reviewer slot.